BIOCHEM SOC T 润色咨询

BIOCHEMICAL SOCIETY TRANSACTIONS

出版年份：1973 年文章数：3772 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：0.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1087856, encodeId=36ae108e85649, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087855, encodeId=0cd5108e85524, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861292, encodeId=e4388612927f, content=审稿速度:1.0<br>经验分享：只收综述，杂志官网上没有投稿链接，要写申请信并指定编辑审核是否符合该刊的收录范围。<br> 审核通过后投稿链接会通过邮箱发给作者，投稿后审稿速度很快，1个月给了小修，修回后2周接收。喜欢收mini review（3000-4000词）。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Jun 02 01:37:58 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851610, encodeId=d06585161099, content=该期刊主要是收录综述类文章（如review，minireview，perspective等）。审稿速度挺快的，三周内就得到了意见。总体觉得挺顺利。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 27 10:32:25 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481354, encodeId=768148135464, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476152, encodeId=d4034e615215, content=偏重的研究方向：生物化学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=503, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d5226231, createdName=webacc, createdTime=Tue Jun 28 15:50:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-12-28 桑晒麦拉

    讨论中局限性怎么撰写？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1087856, encodeId=36ae108e85649, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087855, encodeId=0cd5108e85524, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861292, encodeId=e4388612927f, content=审稿速度:1.0<br>经验分享：只收综述，杂志官网上没有投稿链接，要写申请信并指定编辑审核是否符合该刊的收录范围。<br> 审核通过后投稿链接会通过邮箱发给作者，投稿后审稿速度很快，1个月给了小修，修回后2周接收。喜欢收mini review（3000-4000词）。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Jun 02 01:37:58 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851610, encodeId=d06585161099, content=该期刊主要是收录综述类文章（如review，minireview，perspective等）。审稿速度挺快的，三周内就得到了意见。总体觉得挺顺利。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 27 10:32:25 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481354, encodeId=768148135464, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476152, encodeId=d4034e615215, content=偏重的研究方向：生物化学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=503, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d5226231, createdName=webacc, createdTime=Tue Jun 28 15:50:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2021-12-27 msSSSSSD

    是否需要在讨论中说明文章局限性？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1087856, encodeId=36ae108e85649, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087855, encodeId=0cd5108e85524, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861292, encodeId=e4388612927f, content=审稿速度:1.0<br>经验分享：只收综述，杂志官网上没有投稿链接，要写申请信并指定编辑审核是否符合该刊的收录范围。<br> 审核通过后投稿链接会通过邮箱发给作者，投稿后审稿速度很快，1个月给了小修，修回后2周接收。喜欢收mini review（3000-4000词）。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Jun 02 01:37:58 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851610, encodeId=d06585161099, content=该期刊主要是收录综述类文章（如review，minireview，perspective等）。审稿速度挺快的，三周内就得到了意见。总体觉得挺顺利。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 27 10:32:25 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481354, encodeId=768148135464, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476152, encodeId=d4034e615215, content=偏重的研究方向：生物化学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=503, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d5226231, createdName=webacc, createdTime=Tue Jun 28 15:50:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2020-06-02 ms493637184140865

    审稿速度:1.0
    经验分享：只收综述，杂志官网上没有投稿链接，要写申请信并指定编辑审核是否符合该刊的收录范围。
    审核通过后投稿链接会通过邮箱发给作者，投稿后审稿速度很快，1个月给了小修，修回后2周接收。喜欢收mini review（3000-4000词）。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1087856, encodeId=36ae108e85649, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087855, encodeId=0cd5108e85524, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861292, encodeId=e4388612927f, content=审稿速度:1.0<br>经验分享：只收综述，杂志官网上没有投稿链接，要写申请信并指定编辑审核是否符合该刊的收录范围。<br> 审核通过后投稿链接会通过邮箱发给作者，投稿后审稿速度很快，1个月给了小修，修回后2周接收。喜欢收mini review（3000-4000词）。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Jun 02 01:37:58 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851610, encodeId=d06585161099, content=该期刊主要是收录综述类文章（如review，minireview，perspective等）。审稿速度挺快的，三周内就得到了意见。总体觉得挺顺利。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 27 10:32:25 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481354, encodeId=768148135464, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476152, encodeId=d4034e615215, content=偏重的研究方向：生物化学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=503, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d5226231, createdName=webacc, createdTime=Tue Jun 28 15:50:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2019-05-27 ms9430612511402566

    该期刊主要是收录综述类文章（如review，minireview，perspective等）。审稿速度挺快的，三周内就得到了意见。总体觉得挺顺利。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1087856, encodeId=36ae108e85649, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087855, encodeId=0cd5108e85524, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861292, encodeId=e4388612927f, content=审稿速度:1.0<br>经验分享：只收综述，杂志官网上没有投稿链接，要写申请信并指定编辑审核是否符合该刊的收录范围。<br> 审核通过后投稿链接会通过邮箱发给作者，投稿后审稿速度很快，1个月给了小修，修回后2周接收。喜欢收mini review（3000-4000词）。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Jun 02 01:37:58 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851610, encodeId=d06585161099, content=该期刊主要是收录综述类文章（如review，minireview，perspective等）。审稿速度挺快的，三周内就得到了意见。总体觉得挺顺利。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 27 10:32:25 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481354, encodeId=768148135464, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476152, encodeId=d4034e615215, content=偏重的研究方向：生物化学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=503, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d5226231, createdName=webacc, createdTime=Tue Jun 28 15:50:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2011-06-29 medwu

    看涨哦，如果明天再升一升，有望突破3分

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1087856, encodeId=36ae108e85649, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087855, encodeId=0cd5108e85524, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861292, encodeId=e4388612927f, content=审稿速度:1.0<br>经验分享：只收综述，杂志官网上没有投稿链接，要写申请信并指定编辑审核是否符合该刊的收录范围。<br> 审核通过后投稿链接会通过邮箱发给作者，投稿后审稿速度很快，1个月给了小修，修回后2周接收。喜欢收mini review（3000-4000词）。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baad5414143, createdName=ms493637184140865, createdTime=Tue Jun 02 01:37:58 CST 2020, time=2020-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851610, encodeId=d06585161099, content=该期刊主要是收录综述类文章（如review，minireview，perspective等）。审稿速度挺快的，三周内就得到了意见。总体觉得挺顺利。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9a95414072, createdName=ms9430612511402566, createdTime=Mon May 27 10:32:25 CST 2019, time=2019-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481354, encodeId=768148135464, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=476152, encodeId=d4034e615215, content=偏重的研究方向：生物化学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=503, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8d5226231, createdName=webacc, createdTime=Tue Jun 28 15:50:00 CST 2011, time=2011-06-28, status=1, ipAttribution=)]
    2011-06-28 webacc

    偏重的研究方向：生物化学;

    0

共9条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分